MedTrace Logo

The Validation of the FibriCheck Application for the Detection of Atrial Fibrillation

NCT03620656 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-12-26

No results posted yet for this study

Summary

Optical sensing technologies have the potential to enable long-term heart rhythm monitoring. The medically certified and clinically validated FibriCheck technology has proven its value for spot-check measurements to detect AF. However, further validation and verification of this technology is necessary to evaluate the performance of the FibriCheck technology on different tools (smartphones and smartwatches). During this study the performance of various optical sensors, ranging from the camera in smartphones to the photodetector in smartwatches, will be explored and device and form-factor variability will be investigated. The objective is to define the accuracy of optical sensing systems in the detection of atrial fibrillation versus a reference traditional 12-lead ECG signal.

Conditions

Interventions

DIAGNOSTIC_TEST

FibriCheck

Photoplethysmography-based smartphone or smartwatch sensor to assess cardiac rhythm

Sponsors & Collaborators

  • Qompium NV

    lead INDUSTRY

Principal Investigators

  • Lars Grieten, PhD · CEO

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-07-01
Completion
2019-09-15

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03620656 on ClinicalTrials.gov